Denis Chem Lab Ltd (DENISCHEM) is currently trading at 74.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Denis Chem Lab Ltd is a pharmaceutical company primarily focused on manufacturing sterile intravenous (IV) injectables and transfusion solutions. The company leverages advanced Blow Fill Seal (BFS) technology to produce IV fluids in plastic bottles, reaching a capacity of 15 million units per annum by 2016. In 2021, Denis Chem Lab expanded its production capacity for 100 ml Eurohead 'Aquapulse' products, adding 12,00,000 bottles per month. The company operates a state-of-the-art manufacturing facility that adheres to WHO's GMP specifications, ensuring high-quality pharmaceutical products. Denis Chem Lab's product portfolio includes antibiotic injections, diuretic injections, and plasma volume expanders, highlighting a wide range of specialized medical solutions.

Over the past 52 weeks, Denis Chem Lab Ltd has traded between a low of ₹72.35 and a high of ₹156.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Denis Chem Lab Ltd has a market capitalization of approximately 103.33. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Denis Chem Lab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 14.43 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Denis Chem Lab Ltd (DENISCHEM) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 103.33 Cr, Denis Chem Lab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Denis Chem Lab Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Denis Chem Lab Ltd is 14.43. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Denis Chem Lab Ltd pays dividends with a current dividend yield of 2.01%. Dividend-paying stocks may provide periodic income in addition to potential long-term capital appreciation.

Key risks associated with Denis Chem Lab Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.